lenalidomide has been researched along with Antibody Deficiency Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, SA; Banerjee, PP; Bennett, KL; Bilic, I; Boztug, K; Cagdas, D; Dupré, L; Garncarz, W; Gribben, JG; Hons, M; Hsu, HT; Huppa, JB; Jäger, U; Mace, EM; McClanahan, F; Mukherjee, M; Orange, JS; Petronczki, ÖY; Pfajfer, L; Pickl, WF; Platzer, R; Salzer, E; Sanal, Ö; Sinha, P; Sixt, M; Stockinger, H; Supper, V; Tezcan, I; Willmann, KL; Zlabinger, GJ | 1 |
1 other study(ies) available for lenalidomide and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics.
Topics: Actins; Adolescent; Angiogenesis Inhibitors; B-Lymphocytes; Cell Movement; Cell Proliferation; Child; Cytoskeleton; Cytotoxicity, Immunologic; DNA Mutational Analysis; DNA-Binding Proteins; Dyneins; Female; Guanine Nucleotide Exchange Factors; HEK293 Cells; Humans; Immunoglobulin Class Switching; Immunologic Deficiency Syndromes; Jurkat Cells; Killer Cells, Natural; Lenalidomide; Male; Mutation; Pedigree; RNA, Small Interfering; T-Lymphocytes; Thalidomide | 2016 |